RT Journal Article
SR Electronic
T1 Cytokine status of patients with atherosclerotic injury of carotid arteries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.19.21252052
DO 10.1101/2021.02.19.21252052
A1 Danilova, M.A.
A1 Baidina, T.V.
YR 2021
UL http://medrxiv.org/content/early/2021/02/23/2021.02.19.21252052.abstract
AB The research was aimed at studying interleukin-6 (IL-6), interleukin-10 (IL-10) and C-reactive protein (CRP) levels in serum of 61 patients suffering from atherosclerotic injury of carotid arteries. The results received by the immunoferment method were compared with ultrasound features of atherosclerotic plaques and morphological peculiarities of their biopsies which were obtained during carotid endarterectomy.An increased concentration of cytokines under analysis and CRP in serum of patients with atherosclerotic injury of carotid arteries was detected. It was found out that high levels of IL-6 and CRP are associated with progressing atherosclerosis of carotid arteries and its cerebral complications. The research revealed that detection of cytokines and CRP in serum can be used as an additional method to diagnose unstable character of atherosclerotic plaques.Competing Interest StatementThe authors have declared no competing interest.Funding StatementnoAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Local Ethics Committee of the Perm Medical UniversityAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.